Related Experiment Videos
Probucol inhibits ABCA1-mediated cellular lipid efflux
Elda Favari1, Ilaria Zanotti, Francesca Zimetti
1Department of Pharmacological and Biological Sciences and Applied Chemistry, University of Parma, Parma, Italy.
Arteriosclerosis, Thrombosis, and Vascular Biology
|October 30, 2004
Summary
Probucol significantly inhibits cholesterol efflux mediated by ATP-binding cassette transporter A1 (ABCA1) by preventing its movement to the cell surface. This finding may explain probucol
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- ATP-binding cassette transporter A1 (ABCA1) is crucial for cellular lipid efflux to apolipoproteins.
- Understanding ABCA1 regulation is key for managing lipid metabolism disorders.
Purpose of the Study:
- To investigate the effect of probucol on cellular ABCA1-mediated lipid efflux.
- To elucidate the mechanism by which probucol influences ABCA1 function.
Main Methods:
- Cholesterol efflux assays in various cell lines (J774 macrophages, Fu5AH hepatoma cells, human fibroblasts).
- Confocal microscopy and biotinylation assays to track ABCA1 localization.
- Measurement of apolipoprotein-AI binding to cell surfaces.
Main Results:
- Probucol inhibited ABCA1-mediated cholesterol efflux by up to 80% in J774 cells.
- Probucol impaired ABCA1 translocation from intracellular compartments to the plasma membrane.
- No effect of probucol was observed on scavenger receptor class B, type I (SR-BI)-mediated efflux.
Conclusions:
- Probucol effectively inhibits ABCA1-mediated cholesterol efflux.
- The mechanism involves preventing ABCA1 translocation to the plasma membrane.
- This action may contribute to probucol's in vivo HDL-lowering effects.